Bayer had eight patents in digitalization during Q2 2024. Bayer AG has filed patents for a system and method to process medical images using clinical applications, ensuring accurate study sets are generated. Another patent involves a method for authenticating and tracking patient eligibility to purchase over-the-counter drugs online, enhancing the online sale process for both patients and retailers. GlobalData’s report on Bayer gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Bayer AG - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Bayer had no grants in digitalization as a theme in Q2 2024.

Recent Patents

Application: Systems and methods for processing medical images for in-progress studies (Patent ID: US20240194325A1)

The patent filed by Bayer AG describes a system and method for processing medical images using various clinical applications. The system involves receiving a current study with image series metadata, determining the progress of the study based on the metadata, assembling the study set, processing it using clinical software, and sending the processed study back to the image system. The method aims to reduce network traffic by efficiently handling image data and metadata, ensuring the study is complete before processing.

The computer-implemented method and system focus on receiving, processing, and sending medical images efficiently using clinical software applications. By receiving image series metadata and determining the progress of the study, the system optimizes network traffic and processing time. The method includes various steps such as receiving additional series metadata, sending status queries, and applying relevancy matching rules to ensure accurate processing of the medical images. Overall, the patent aims to streamline the processing of medical images in a communication network while reducing network traffic and ensuring the completeness of the study before processing.

To know more about GlobalData’s detailed insights on Bayer, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.